GLI-2 Antibody [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # AF3526H

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Chromatin Immunoprecipitation (ChIP), Immunohistochemistry, Western Blot
Label
HRP
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human GLI-2
Ala2-Glu91
Accession # BAA25668
Ala2-Glu91
Accession # BAA25668
Specificity
Detects human GLI-2 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 25% cross-reactivity with recombinant mouse GLI-2 and 5% cross-reactivity with recombinant human (rh) GLI-1 and rhGLI-3 is observed.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for GLI-2 Antibody [HRP]
Application
Recommended Usage
Chromatin Immunoprecipitation (ChIP)
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: GLI-2
Long Name
GLI-Kruppel family member GLI2
Alternate Names
GLI2, THP2
Gene Symbol
GLI2
Additional GLI-2 Products
Product Documents for GLI-2 Antibody [HRP]
Product Specific Notices for GLI-2 Antibody [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...